| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -855K | 100% | $2.36 | -$2.02M |
| Net | -1 | -855K | -100% | -$2.02M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Decheng Capital China Life Sciences USD Fund III, L.P. | 10%+ Owner | $7.04M | -$2.02M | -22.3% | Oct 16, 2025 |
| Matthew Kirkby | Director | Apr 21, 2025 | |||
| Patrick Fabbio | Director | Apr 21, 2025 | |||
| Brendan Delaney | Director | Apr 21, 2025 | |||
| Lan Huang | Chief Executive Officer, Director, 10%+ Owner | Apr 21, 2025 | |||
| Jiangwen Majeti | Director | Apr 21, 2025 | |||
| Sihai Xu | Director | Apr 21, 2025 | |||
| Yingjuan June Lu | Chief Scientific Officer | Apr 21, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|